EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ST3GAL1 Promotes Malignant Phenotypes in Intrahepatic Cholangiocarcinoma

Fanghua Chen, Ke Gao, Yan Li, Yin Li, Yingcheng Wu, Liangqing Dong, Zijian Yang, Jieyi Shi, Kun Guo, Qiang Gao, Haojie Lu, Shu Zhang

Molecular & Cellular Proteomics · 2024-09 · 23 (9) · 100821

DOI: 10.1016/j.mcpro.2024.100821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2024-09. Verfasst von Fanghua Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai,…. Hauptthemen laut MEDLINE: beta-Galactoside alpha-2,3-Sialyltransferase, Bile Duct Neoplasms, Cholangiocarcinoma. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intrahepatic cholangiocarcinoma (iCCA) has a poor prognosis, and elucidation of the molecular mechanisms underlying iCCA malignancy is of great significance. Glycosylation, an important post-translational modification, is closely associated with tumor progression. Altered glycosylation, including aberrant sialylation resulting from abnormal expression of sialyltransferases (STs) and neuraminidases (NEUs), is a significant feature of cancer cells. However, there is limited information on the roles of STs and NEUs in iCCA malignancy. Here, utilizing our proteogenomic resources from a cohort of 262 patients with iCCA, we identified ST3GAL1 as a prognostically relevant molecule in iCCA. Moreover, overexpression of ST3GAL1 promoted proliferation, migration, and invasion and inhibited apoptosis of iCCA cells in vitro. Through proteomic analyses, we identified the downstream pathway potentially regulated by ST3GAL1, which was the NF-κB signaling pathway, and further demonstrated that this pathway was positively correlated with malignancy in iCCA cells. Notably, glycoproteomics showed that O-glycosylation was changed in iCCA cells with high ST3GAL1 expression. Importantly, the altered O-glycopeptides underscored the potential utility of O-glycosylation profiling as a discriminatory marker for iCCA cells with ST3GAL1 overexpression. Additionally, miR-320b was identified as a post-transcriptional regulator of ST3GAL1, capable of suppressing ST3GAL1 expression and then reducing the proliferation, migration, and invasion abilities of iCCA cell lines. Taken together, these results suggest ST3GAL1 could serve as a promising therapeutic target for iCCA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-Galactoside alpha-2,3-SialyltransferaseBile Duct NeoplasmsCholangiocarcinomaFemaleHumansMaleMiddle AgedApoptosisCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticGlycosylationNeoplasm InvasivenessNF-kappa BPhenotypePrognosisProteomicsSialyltransferasesSignal Transduction

Stichwörter der Autor:innen

NF-κB signaling pathwayST3GAL1glycosylationintrahepatic cholangiocarcinomamiR-320b

Substanzen

beta-Galactoside alpha-2,3-SialyltransferaseNF-kappa BSialyltransferasesST3GAL1 protein, human

Autor:innen und Institutionen

  • Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China.
  • Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China; Department of Chemistry and NHC Key Laboratory of Glycoconjuga…
  • Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China. Electronic address: zhang.shu@zs-hospital.sh.cn.

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • National Key Research and Development Program of China Stem Cell and Translational Research

Zitieren

APA

Chen, F., Gao, K., Li, Y., Li, Y., Wu, Y., Dong, L., Yang, Z., Shi, J., Guo, K., Gao, Q., Lu, H., & Zhang, S. (2024). ST3GAL1 Promotes Malignant Phenotypes in Intrahepatic Cholangiocarcinoma. Molecular & Cellular Proteomics, 23(9), 100821. https://doi.org/10.1016/j.mcpro.2024.100821

Vancouver

Chen F, Gao K, Li Y, Li Y, Wu Y, Dong L, et al. ST3GAL1 Promotes Malignant Phenotypes in Intrahepatic Cholangiocarcinoma. Molecular & Cellular Proteomics. 2024;23(9):100821. doi:10.1016/j.mcpro.2024.100821

BibTeX
@article{Chen2024,
  author = {Chen, Fanghua and Gao, Ke and Li, Yan and Li, Yin and Wu, Yingcheng and Dong, Liangqing and Yang, Zijian and Shi, Jieyi and Guo, Kun and Gao, Qiang and Lu, Haojie and Zhang, Shu},
  title = {ST3GAL1 Promotes Malignant Phenotypes in Intrahepatic Cholangiocarcinoma},
  journal = {Molecular & Cellular Proteomics},
  year = {2024},
  volume = {23},
  number = {9},
  pages = {100821},
  doi = {10.1016/j.mcpro.2024.100821}
}
Kostenlos starten →